Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-24

Clinical Trial Update: Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections [Phase 4]

View source ↗

Summary

Phase 4 trial comparing oxytocin given intramuscularly or intravenously to carbetocin IV for elective cesarean sections in postpartum hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbetocin (carbetocin)
  • Oxytocin (Oxytocin)

Snippet

Sponsor: University of Zurich | Conditions: Postpartum Hemorrhage | Phase 4 | Status: COMPLETED